Literature DB >> 3948163

Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.

A Krishan, A Sauerteig, K Gordon, C Swinkin.   

Abstract

Cellular accumulation of daunorubicin (DNR), N-trifluoroacetyl-adriamycin-14-valerate, and THP-Adriamycin (THP-ADR) in doxorubicin sensitive and resistant murine leukemic P388 cells was studied with laser excited flow cytometry. Appearance of DNR fluorescence in P388/S cells was rapid in contrast to that of P388/R cells. A comparison of P388/S and P388/R cells incubated for 20-30 min showed that DNR fluorescence in P388/R cells was one-sixth that of P388/S cells. In contrast, the difference between fluorescence value of P388/S and P388/R cells similarly incubated with N-trifluoroacetyl-adriamycin-14-valerate or THP-ADR was less than 2-fold. Chlorpromazine, verapamil, and trifluoperazine increased the cellular accumulation and cytotoxicity of DNR and THP-ADR but had no major effect on N-trifluoroacetyl-adriamycin-14-valerate fluorescence or cytotoxicity in P388/R cells. Fluorometric and soft agar assays confirmed the data on the effect of these modulators on drug accumulation obtained by the more rapid method of laser flow cytometry.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948163

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.

Authors:  F W Busch; U Schmittele; G Ehninger
Journal:  Blut       Date:  1990-04

3.  Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.

Authors:  G Han; M Israel; R Seshadri; J T Dalton; T W Sweatman
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker.

Authors:  K S Sridhar; A Krishan; T S Samy; R C Duncan; A Sauerteig; G V McPhee; M E Auguste; P W Benedetto
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Multidrug resistance (mdr) genes in human cancer.

Authors:  K Nooter; H Herweijer
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

6.  Flow cytometric analysis of early steps in development of adriamycin resistance in a human gastric cancer cell line.

Authors:  S Tanaka; K Aizawa; N Katayanagi; O Tanaka
Journal:  Jpn J Cancer Res       Date:  1994-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.